Blue Cross Laboratories Private Limited, a active private limited company, was established on 09 July 1980 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24230MH1980PTC022825. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹100.00 Cr and a paid-up capital of ₹64.80 Cr.
Formerly known as Blue Cross Laboratories Limited. It upholds a compliant status. Employing 2,801 professional, Its leadership includes Ketki Raj Wadhawa (Director), Bhalchandra Barve Govind (Managing Director), Rohit Jayaramdas Patel (Director). Past directors included Anup Kumar Romesh Burman, Ketki Raj Wadhawa, Haresh Nihchal Israni. It holds no open charges and ₹10.35 Cr settled loans. Its latest AGM occurred on 08 May 2025, with the balance sheet filed on 31 March 2025. It is based at Peninsula Chambers, Peninsula Corporate Park Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra, 400013.
U24230MH1980PTC022825
022825
09 July 1980
₹100.00 Cr
₹64.80 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Blue Cross Laboratories Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Ketki Raj Wadhawa | Director | 15 Apr 2020 | Current |
| Bhalchandra Barve Govind | Managing Director | 18 May 1998 | Current |
| Rohit Jayaramdas Patel | Director | 05 Dec 2007 | Current |
| Rajendra Yeshwant Padhye | Director | 17 Nov 2010 | Current |
| Ashish Mangesh Shirsat | Whole-Time Director | 01 Sep 2006 | Current |
| Manoj Nihchal Israni | Managing Director | 21 Jun 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Jun 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Jun 2020 | Past |
| Pramod Abcsdd | Director | 22 May 2010 | Past |
| Pramod Abcsdd | Whole-Time Director | 01 Jan 2010 | Past |
| Pramod Abcsdd | Director | 28 Nov 2007 | Past |
| Pramod Abcsdd | Whole-Time Director | 29 Dec 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Blue Cross Laboratories Private Limited, for the financial year ended 2025, experienced modest growth in revenue, with a 4.78% increase. The company also saw a slight improvement in profitability, with a 4.77% increase in profit. The company's net worth dipped by a decrease of 3.47%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2025, Blue Cross Laboratories had a promoter holding of 80.43% and a public holding of 19.57%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹0
₹103,500,000.00
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Jan 1999 | Central Bank Of India (Lead Bank ) | ₹10.35 Cr | Satisfied |
Explore comprehensive loan charge details -
Blue Cross Laboratories has a workforce of 2801 employees as of Nov 22, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Blue Cross Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Blue Cross Laboratories's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Blue Cross Laboratories Private Limited last Annual general meeting of members was held on 08 May 2025 as per latest MCA records. was documented.
Progress on Blue Cross Laboratories Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai. was documented.
Progress on Ketki Raj Wadhawa was appointed as a Director was appointed as a Director on 15 Apr 2020 & has been associated with this company since 5 years 7 months . was documented.
Manoj Nihchal Israni was appointed as a Managing Director was appointed as a Managing Director on 21 Jun 2018 & has been associated with this company since 7 years 5 months . was recorded as a recent event.
The activity A charge registered on 07 Jan 1999 via Charge ID 80042579 with Central Bank Of India (Lead Bank ) was fully satisfied on 22 Feb 2016. was completed.
The activity Rajendra Yeshwant Padhye was appointed as a Director was appointed as a Director on 17 Nov 2010 & has been associated with this company since 15 years 12 days . was completed.
When you buy Hemp Heaven, you're not just getting a great product, you're also supporting a company that cares about quality and wellness. With their recent acquisition, Great Buy Products is expanding their reach and offering even more amazing skincare options. Plus, they're stepping up their marketing game and making it easier for you to find and buy their products. Check out www.hempheaven.com for all your hemp skincare needs!.
The company was part of many Pharma companies which received fresh summons under Goods and Services Tax in the New Year, ET had reported earlier..
The CIN of Blue Cross Laboratories Private Limited is U24230MH1980PTC022825.
Blue Cross Laboratories Private Limited is headquartered at Peninsula Chambers, Peninsula Corporate Park Ganpatrao Kadam Marg, Lower Parel, Mumbai, Maharashtra, 400013.
Blue Cross Laboratories Private Limited was incorporated on 09 July 1980.
The current directors of Blue Cross Laboratories Private Limited are
The primary industry of Blue Cross Laboratories Private Limited is Manufacturing.
Blue Cross Laboratories Private Limited is unlisted.
The authorized capital of Blue Cross Laboratories Private Limited is ₹100.00 Cr, and the paid-up capital is ₹64.80 Cr.
The compliance status of Blue Cross Laboratories Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX